This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakayama, H.
Right arrow Articles by Aoki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakayama, H.
Right arrow Articles by Aoki, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2001, p. 3037-3045, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3037-3045.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

In Vitro and In Vivo Effects of 14alpha -Demethylase (ERG11) Depletion in Candida glabrata

Hironobu Nakayama,1,* Noboru Nakayama,2,dagger Mikio Arisawa,1,Dagger and Yuko Aoki1,Dagger

Department of Mycology1 and Department of Spectroscopic Analysis,2 Nippon Roche K. K. Research Center, Kanagawa 247-8530, Japan

Received 2 October 2000/Returned for modification 13 November 2000/Accepted 14 August 2001

Sterol 14alpha -demethylase (ERG11) is the target enzyme of azole antifungals that are widely used for the treatment of fungal infections. Candida glabrata is known to be less susceptible to fluconazole than most Candida albicans strains, and the incidence of C. glabrata infection has been increasing mostly in conjunction with the use of azole antifungals. Recently, it has been reported that C. glabrata can rescue the defect of ergosterol biosynthesis by incorporating cholesterol from serum. To explore the effect of inactivating Erg11p in C. glabrata, we generated mutant strains in which the ERG11 gene was placed under the control of tetracycline-regulatable promoters. In these mutants, expression of the ERG11 gene can be repressed by doxycycline (DOX). All mutants showed a growth defect in the presence of DOX. The numbers of CFU of the mutants were lowered by only 1/10 with DOX treatment. In these mutants, accumulation of 4,14-dimethylzymosterol, which differs from an accumulated abnormal sterol detected in C. albicans and Saccharomyces cerevisiae treated with fluconazole, was observed by DOX treatment. Although such phenotypes were also observed in serum-containing media by DOX treatment, they were alleviated. Furthermore, the mutant could grow in DOX-treated mice without a severe reduction in the number of cells. Thus, depleting the expression of the ERG11 gene lowered the number of CFU by only 1/10 due to the accumulation of 4,14-demethylzymosterol in vitro, and it did not result in the defective growth of fungal cells in mice. These results suggested that Erg11p is not an ideal target molecule of antifungals for C. glabrata.


* Corresponding author. Present address: Department of Oncology, Nippon Roche K. K. Research Center, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan. Phone: 81-467-47-2218. Fax: 81-467-45-6782. E-mail: hironobu.nakayama{at}roche.com.

dagger Present address: Department of Chemistry, Nippon Roche K. K. Research Center, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.

Dagger Present address: Department of Oncology, Nippon Roche K. K. Research Center, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.


Antimicrobial Agents and Chemotherapy, November 2001, p. 3037-3045, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3037-3045.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhauser, J., Rogers, P. D. (2008). A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate. Eukaryot Cell 7: 1180-1190 [Abstract] [Full Text]  
  • Nakayama, H., Tanabe, K., Bard, M., Hodgson, W., Wu, S., Takemori, D., Aoyama, T., Kumaraswami, N. S., Metzler, L., Takano, Y., Chibana, H., Niimi, M. (2007). The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. J Antimicrob Chemother 60: 1264-1272 [Abstract] [Full Text]  
  • Mellado, E., Garcia-Effron, G., Buitrago, M. J., Alcazar-Fuoli, L., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2005). Targeted Gene Disruption of the 14-{alpha} Sterol Demethylase (cyp51A) in Aspergillus fumigatus and Its Role in Azole Drug Susceptibility. Antimicrob. Agents Chemother. 49: 2536-2538 [Abstract] [Full Text]  
  • Munayyer, H. K., Mann, P. A., Chau, A. S., Yarosh-Tomaine, T., Greene, J. R., Hare, R. S., Heimark, L., Palermo, R. E., Loebenberg, D., McNicholas, P. M. (2004). Posaconazole Is a Potent Inhibitor of Sterol 14{alpha}-Demethylation in Yeasts and Molds. Antimicrob. Agents Chemother. 48: 3690-3696 [Abstract] [Full Text]  
  • Tsai, H.-F., Bard, M., Izumikawa, K., Krol, A. A., Sturm, A. M., Culbertson, N. T., Pierson, C. A., Bennett, J. E. (2004). Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension. Antimicrob. Agents Chemother. 48: 2483-2489 [Abstract] [Full Text]  
  • Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., Bille, J. (2003). Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents. Antimicrob. Agents Chemother. 47: 2404-2412 [Abstract] [Full Text]  
  • Morales, I. J., Vohra, P. K., Puri, V., Kottom, T. J., Limper, A. H., Thomas, C. F. Jr. (2003). Characterization of a Lanosterol 14{alpha}-Demethylase from Pneumocystis carinii. Am. J. Respir. Cell Mol. Bio. 29: 232-238 [Abstract] [Full Text]